BAMBOOSHEALTH (02293) issued a profit warning, forecasting that the annual net profit attributable to shareholders will be approximately HKD 6 million to HKD 7 million, a year-on-year decrease.

BAMBOOSHEALTH (02293) issued an announcement, expecting that the net profit attributable to shareholders for the financial year ending June 30, 2026, will be approximately HKD 6 million to HKD 7 million, compared to the net audited consolidated profit attributable to shareholders of approximately HKD 17.5 million for the financial year ending June 30, 2025. The Board believes that the decrease in net profit attributable to shareholders is primarily due to the following factors: the decline in the Group's revenue, mainly in the institutional healthcare personnel solutions segment, which decreased from HKD 35.1 million last year to approximately HKD 22 million to HKD 23 million. This decrease is attributed to policies implemented by the Hong Kong government to address workforce shortages, particularly the introduction of labor importation programs bringing in nurses and caregivers from overseas (mainly from Mainland China). These policies increased the labor supply for institutional healthcare clients, intensifying market competition. Other losses increased by approximately HKD 2 million to HKD 3 million compared to last year, mainly due to foreign exchange differences arising from currency transactions. The direct costs in the clinic services segment increased by approximately HKD 2 million to HKD 3 million, primarily due to rising costs of medications and testing compared to last year.